ProCE Banner Activity

Mini-HCVD + Inotuzumab Ozogamicin as Frontline Therapy in Older Adults With ALL

Slideset Download
Conference Coverage
Addition of targeted therapy to chemotherapy increased efficacy with low rate of severe AEs.

Released: December 07, 2015

Expiration: December 05, 2016

No longer available for credit.

Share

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

Amgen, Inc.

Celgene

Incyte

Merck & Co., Inc.

Millennium Takeda

Seagen